First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea
Ki Hoon Kim1, Ju Sun Song2, Chan Wook Park1
1Department of Neurology, Epilepsy Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Abstract:
Unverricht-Lundborg disease (ULD) is a form of progressive myoclonus epilepsy characterized by stimulation-induced myoclonus and seizures. This disease is an autosomal recessive disorder, and the gene CSTB, which encodes cystatin B, a cysteine protease inhibitor, is the only gene known to be associated with ULD. Although the prevalence of ULD is higher in the Baltic region of Europe and the Mediterranean, sporadic cases have occasionally been diagnosed worldwide. The patient described in the current report showed only abnormally enlarged restriction fragments of 62 dodecamer repeats, confirming ULD, that were transmitted from both her father and mother who carried the abnormally enlarged restriction fragment as heterozygotes with normal-sized fragments. We report the first case of a genetically confirmed patient with ULD in Korea.
Related Concept Videos
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Molecular Models
Molecular Orbital Theory II
Molecular Orbital Theory I
Formulating and Validating Nursing Diagnosis I
There are thirteen domains...


